萘普生和保泰松治疗急性痛风的多中心试验。
Multicentre trial of naproxen and phenylbutazone in acute gout.
作者信息
Sturge R A, Scott J T, Hamilton E B, Liyanage S P, Dixon A S, Davies J, Engler C
出版信息
Ann Rheum Dis. 1977 Feb;36(1):80-2. doi: 10.1136/ard.36.1.80.
Abstract
Naproxen 750 mg as a single dose followed by 250 mg three times daily has been compared with phenylbutazone 200 mg four times daily for 48 hours followed by 200 mg three times daily for treatment of acute gout in an open study on 41 patients. The drugs were equally effective with few and relatively mild side effects. Naproxen is a useful alternative agent for the treatment of acute gout.
摘要
在一项针对41名患者的开放性研究中，将萘普生单次服用750毫克，随后每日三次、每次250毫克的用药方案，与保泰松每日四次、每次200毫克服用48小时，随后每日三次、每次200毫克的用药方案进行了比较，用于治疗急性痛风。两种药物疗效相当，副作用少且相对较轻。萘普生是治疗急性痛风的一种有用的替代药物。
相似文献
1
Multicentre trial of naproxen and phenylbutazone in acute gout.萘普生和保泰松治疗急性痛风的多中心试验。
Ann Rheum Dis. 1977 Feb;36(1):80-2. doi: 10.1136/ard.36.1.80.
2
Multi-centre trial of naproxen and phenylbutazone in acute gout.
Adv Exp Med Biol. 1977;76B:290-6. doi: 10.1007/978-1-4684-3285-5_44.
3
[Pharmacotherapy in uratic arthritis. I].
Tidsskr Nor Laegeforen. 1977 May 10;97(13):656.
4
The treatment of acute gout with naproxen.
J Clin Pharmacol. 1975 Apr;15(4 Pt. 2):363-6. doi: 10.1002/j.1552-4604.1975.tb01465.x.
5
[Methoxypropriocin in the treatment of gout].
Wiad Lek. 1976 Oct 15;29(20):1791-3.
6
Chemistry and pharmacology of naproxen.萘普生的化学与药理学
Arzneimittelforschung. 1975 Feb;25(2A):278-81.
7
Clinical and objective assessments of naproxen through 5 years of clinical experience.通过5年临床经验对萘普生进行的临床和客观评估。
Arzneimittelforschung. 1975 Feb;25(2A):327-32.
8
Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis.萘普生和保泰松治疗强直性脊柱炎的双盲试验。
Ann Rheum Dis. 1978 Feb;37(1):85-8. doi: 10.1136/ard.37.1.85.
9
Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis.氟比洛芬与保泰松治疗急性痛风性关节炎的双盲试验
Br J Clin Pharmacol. 1985 Nov;20(5):511-3. doi: 10.1111/j.1365-2125.1985.tb05110.x.
10
[Observations of long-term treatment of arthrosis with naproxen].
Arzneimittelforschung. 1975 Feb;25(2A):325-7.
引用本文的文献
1
Non-steroidal anti-inflammatory drugs for acute gout.非甾体抗炎药治疗急性痛风。
Cochrane Database Syst Rev. 2021 Dec 9;12(12):CD010120. doi: 10.1002/14651858.CD010120.pub3.
2
Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis.传统非选择性非甾体抗炎药与选择性环氧化酶-2抑制剂治疗急性痛风患者的疗效比较：系统评价与荟萃分析
BMJ Open. 2020 Sep 10;10(9):e036748. doi: 10.1136/bmjopen-2019-036748.
3
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative.多国循证推荐意见：痛风的诊断与管理——3e 倡议中广泛的风湿病学家专家组对系统文献回顾和专家意见的整合。
Ann Rheum Dis. 2014 Feb;73(2):328-35. doi: 10.1136/annrheumdis-2013-203325. Epub 2013 Jul 18.
4
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.2012年美国风湿病学会痛风管理指南。第2部分：急性痛风性关节炎的治疗与抗炎预防
Arthritis Care Res (Hoboken). 2012 Oct;64(10):1447-61. doi: 10.1002/acr.21773.
5
Matching the Drug to the Patient: The rational use of antiarthritic drugs.对症选药：抗风湿药物的合理应用。
Can Fam Physician. 1991 Jan;37:159-67.
6
Systemic corticosteroids for acute gout.用于急性痛风的全身性皮质类固醇
Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD005521. doi: 10.1002/14651858.CD005521.pub2.
7
Clinical trials: proposal for an international coding system (ICS).临床试验：国际编码系统（ICS）提案。
Br J Clin Pharmacol. 1984 Feb;17(2):117-23. doi: 10.1111/j.1365-2125.1984.tb02325.x.
8
Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis.氟比洛芬与保泰松治疗急性痛风性关节炎的双盲试验
Br J Clin Pharmacol. 1985 Nov;20(5):511-3. doi: 10.1111/j.1365-2125.1985.tb05110.x.
9
Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.萘普生最新进展：对其药理特性、治疗效果以及在风湿性疾病和疼痛状态中的应用的综述。
Drugs. 1979 Oct;18(4):241-77. doi: 10.2165/00003495-197918040-00001.
10
New knowledge of the pathogenesis of gout.痛风发病机制的新知识。
J Clin Pathol Suppl (R Coll Pathol). 1978;12:205-13.
本文引用的文献
1
208.--INDOMETHACIN IN THE TREATMENT OF ACUTE GOUT.208.——消炎痛治疗急性痛风
Practitioner. 1965 Apr;194:560-5.
2
Gout.
Arthritis Rheum. 1962 Dec;5:624-33. doi: 10.1002/art.1780050611.
3
Oral phenylbutazone in the treatment of acute gouty arthritis.
Am J Med. 1956 Aug;21(2):232-6. doi: 10.1016/0002-9343(56)90056-0.
4
Crystal induced inflammation in canine joints. 3. Evidence against bradykinin as a mediator of inflammation.
J Lab Clin Med. 1966 Sep;68(3):433-44.
5
Treatment of primary gout: the present status.
Arthritis Rheum. 1965 Oct;8(5):911-20. doi: 10.1002/art.1780080502.
6
New Haven survey of joint diseases. The prediction of serum uric acid in a general population.纽黑文关节疾病调查。普通人群血清尿酸的预测。
J Chronic Dis. 1969 Jan;21(8):543-53. doi: 10.1016/0021-9681(69)90050-2.
7
Crystal-induced arthritis.晶体性关节炎
Postgrad Med. 1969 Jan;45(1):87-93. doi: 10.1080/00325481.1969.11696985.
8
Acute gouty arthritis and response to colchicine in the virtual absence of synovial-fluid leukocytes.
N Engl J Med. 1974 Jun 13;290(24):1363-4. doi: 10.1056/NEJM197406132902406.
9
Urate crystal arthritis in animals lacking Hageman factor.
Arthritis Rheum. 1974 Mar-Apr;17(2):143-8. doi: 10.1002/art.1780170206.
10
Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicle.牛精囊花生四烯酸加氧酶（前列腺素合成酶）系统生成的前列腺素和丙二醛的定量测定。
Prostaglandins. 1973 Sep;4(3):325-41. doi: 10.1016/0090-6980(73)90020-8.
Zotero 插件